LuckCong's Health Blog

Some medical examination found that hepatitis B surface antigen positive, they panic, do not worry about sleep. This need for the treatment of patients in the end? What should we do? Means that the hepatitis B surface antigen-positive infections, but does not necessarily mark the presence of hepatitis B have. In such patients should undergo further examination, including hepatitis B, "two pairs of semi-", the virus genes (DNA), ultrasound liver and spleen, liver function tests previously. If the lack of clinical symptoms, liver and spleen is not enlarged, a normal liver function, the silent majority to carry the state. For such patients should focus on maintaining stability in the body immunity should not be blind by enhancing immune function to clear the virus, because on the one hand, too many drugs will increase the burden on the liver, on the other hand, once immune tolerance is broken, will result in the immune system The infection attacks the liver cells and then change induced liver disease. Interferon for the majority of such patients is invalid. If necessary, can be used nucleoside drugs, such direct anti-viral drugs, has little to do with the immune system. For transaminase repeatedly increased, and more severe symptoms, surface antigen, E antigen, the core antibody were positive for the so-called "Dasan Yang" in patients with chronic hepatitis B, necessary to carry out anti-virus and anti-liver fibrosis treatment. In order to rapidly inhibit viral replication and reduce damage to liver cells and reduce liver fibrosis, thus blocking the occurrence of liver cirrhosis. Even if the patient is not "Dasan Yang," but as long as long-term abnormal liver function, or have cirrhosis of the early performance of the need anti-retroviral therapy. Application of the virus may have a direct inhibitory effect of the drug can also be applied immunomodulatory drugs through enhanced immune function and inhibit the virus. Interferon is a legal drug, traditional Chinese medicine in Sophora, umbellatus polysaccharide, and so bitter Phyllanthus has a certain effect, according to the infection, liver function, immune status and procedures for the treatment of immune-designed, inexpensive, well Period are often good effect. The surface antigen positive, E antibody-positive core of the so-called "Xiao Sanyang," patients should be treated different from the specific situation. If after a hepatitis outbreak or formal anti-viral treatment, "Dasan Yang" to "Xiao Sanyang," often means that the disease rehabilitation; if serum viral genes are still high and abnormal liver function, viral mutation that often. In our patients with chronic hepatitis in 70% of the variation around this phenomenon. As a result of this variation of the virus to evade immune surveillance, often prone to the development of severe chronic hepatitis, cirrhosis, liver cancer more closely related. For such patients is similar to the aforementioned "Dasan Yang" chronic hepatitis B, but treatment is often more difficult, often takes several drug treatment; to have a family history of liver cancer, age above 35-year-old male, "Xiao Sanyang "Patients, on a regular basis that anti-virus or immune regulation therapy to prevent occurrence of liver cancer. Singapore, according to a report of 82 cases of patients to receive treatment on a regular basis, 3 years, no case of liver cancer occur, not to accept the treatment of 18 cases occurred in 3 cases of liver cancer. For patients with cirrhosis have been, should be based on inhibiting virus, anti-fibrosis treatment, and so on. In order to alleviate liver damage, to prevent the development of decompensation. Nucleotides have a long-term inhibition; regular application of low-dose interferon can prevent liver cancer. However, if the conditions in decompensated, it would be inappropriate application of interferon. Several experts repeatedly stressed that the pathology of hepatitis B is complex, varied performance, treatment should be individualized, seeking a "panacea" for the "cure" is more harm than good for.